The effects of sunitinib malate used in targeted therapy on the proliferation of HeLa cells in vitro

dc.contributor.author	Tekisogullari, K.
dc.contributor.author	Topcul, MEHMET RIFKI
dc.date.accessioned	2021-03-05T17:15:58Z
dc.date.available	2021-03-05T17:15:58Z
dc.date.issued	2013
dc.identifier.citation	Tekisogullari K., Topcul M. R. , "The effects of sunitinib malate used in targeted therapy on the proliferation of HeLa cells in vitro", JOURNAL OF BUON, cilt.18, ss.253-260, 2013
dc.identifier.issn	1107-0625
dc.identifier.other	vv_1032021
dc.identifier.other	av_c4adbe35-14cd-45f6-80b0-eeeb5dba6d72
dc.identifier.uri	http://hdl.handle.net/20.500.12627/130443
dc.description.abstract	Purpose: In this study, the antiproliferative and apoptotic effects of sunitinib (SU-11248, Sutent) which is used for targeted therapy was evaluated on HeLa cell line originated from human cervix carcinoma.
dc.language.iso	eng
dc.subject	Onkoloji
dc.subject	Sağlık Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Dahili Tıp Bilimleri
dc.subject	Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	The effects of sunitinib malate used in targeted therapy on the proliferation of HeLa cells in vitro
dc.type	Makale
dc.relation.journal	JOURNAL OF BUON
dc.contributor.department	İstanbul Üniversitesi , ,
dc.identifier.volume	18
dc.identifier.issue	1
dc.identifier.startpage	253
dc.identifier.endpage	260
dc.contributor.firstauthorID	59621

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.